SE
60
-5
URBN
66
2
HSY
43
3
HUM
48
2
GS
75
-4
DD
61
4
CSX
68
3
XOM
51
3
BLK
70
-2
CF
53
2
SLG
62
-4
DOV
73
4
NSC
64
2
AMG
43
3
ABT
57
-5
CMS
58
-2
NOV
58
-2
JCI
61
-2
BMY
61
-3
TROW
51
-2
SE
60
-5
URBN
66
2
HSY
43
3
HUM
48
2
GS
75
-4
DD
61
4
CSX
68
3
XOM
51
3
BLK
70
-2
CF
53
2
SLG
62
-4
DOV
73
4
NSC
64
2
AMG
43
3
ABT
57
-5
CMS
58
-2
NOV
58
-2
JCI
61
-2
BMY
61
-3
TROW
51
-2
Financhill
Back

China SXT Pharmaceuticals 10K Form

Sell
25

SXTC
China SXT Pharmaceuticals

Last Price:
0.45
Seasonality Move:
12.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SXTC News And Ratings

See the #1 stock for the next 7 days that we like better than SXTC

SXTC Financial Statistics

Sales & Book Value

Annual Sales: $1.93M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $6.28
Price / Book: 0.12

Profitability

EPS (TTM): -16.36570
Net Income (TTM): $-3.1M
Gross Margin: $553.97K
Return on Equity: -27.59%
Return on Assets: -13.82%

China SXT Pharmaceuticals Earnings Forecast

Key China SXT Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 8 years for SXTC is 28.73%.
  • The Selling, General & Administrative Expenses for SXTC have been equal to 159.15% of Gross Profit Margin.
  • The Interest Expense is -17.57% of Operating Income.
  • The Net Earning history of SXTC is -160.67% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

China SXT Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SXTC
CUSIP: G2161P
Website: sxtchina.com

Debt

Debt-to-Equity Ratio: 0.17
Current Ratio: 1.6
Quick Ratio: 1.51

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SXTC Technical Analysis vs Fundamental Analysis

Sell
25
China SXT Pharmaceuticals (SXTC) is a Sell

Is China SXT Pharmaceuticals a Buy or a Sell?